These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
567 related articles for article (PubMed ID: 32998300)
1. Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications. Hashiesh HM; Meeran MFN; Sharma C; Sadek B; Kaabi JA; Ojha SK Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998300 [TBL] [Abstract][Full Text] [Related]
2. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid. Hashiesh HM; Sharma C; Goyal SN; Sadek B; Jha NK; Kaabi JA; Ojha S Biomed Pharmacother; 2021 Aug; 140():111639. PubMed ID: 34091179 [TBL] [Abstract][Full Text] [Related]
3. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Jha NK; Sharma C; Hashiesh HM; Arunachalam S; Meeran MN; Javed H; Patil CR; Goyal SN; Ojha S Front Pharmacol; 2021; 12():590201. PubMed ID: 34054510 [TBL] [Abstract][Full Text] [Related]
4. Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors. Youssef DA; El-Fayoumi HM; Mahmoud MF Biomed Pharmacother; 2019 Feb; 110():145-154. PubMed ID: 30469079 [TBL] [Abstract][Full Text] [Related]
5. β-Caryophyllene, a Dietary Phytocannabinoid, Alleviates Diabetic Cardiomyopathy in Mice by Inhibiting Oxidative Stress and Inflammation Activating Cannabinoid Type-2 Receptors. Mamdouh Hashiesh H; Sheikh A; Meeran MFN; Saraswathiamma D; Jha NK; Sadek B; Adeghate E; Tariq S; Al Marzooqi S; Ojha S ACS Pharmacol Transl Sci; 2023 Aug; 6(8):1129-1142. PubMed ID: 37588762 [TBL] [Abstract][Full Text] [Related]
6. Beta-caryophyllene protects against diet-induced dyslipidemia and vascular inflammation in rats: Involvement of CB2 and PPAR-γ receptors. Youssef DA; El-Fayoumi HM; Mahmoud MF Chem Biol Interact; 2019 Jan; 297():16-24. PubMed ID: 30343038 [TBL] [Abstract][Full Text] [Related]
7. Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise. Sharma C; Al Kaabi JM; Nurulain SM; Goyal SN; Kamal MA; Ojha S Curr Pharm Des; 2016; 22(21):3237-64. PubMed ID: 26965491 [TBL] [Abstract][Full Text] [Related]
8. β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties. Fidyt K; Fiedorowicz A; Strządała L; Szumny A Cancer Med; 2016 Oct; 5(10):3007-3017. PubMed ID: 27696789 [TBL] [Abstract][Full Text] [Related]
9. Insulinotropic and antidiabetic effects of β-caryophyllene with l-arginine in type 2 diabetic rats. Kumawat VS; Kaur G J Food Biochem; 2020 Apr; 44(4):e13156. PubMed ID: 31997410 [TBL] [Abstract][Full Text] [Related]
10. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates β-adrenergic agonist-induced myocardial injury in a cannabinoid receptor-2 dependent and independent manner. Meeran MFN; Laham F; Azimullah S; Sharma C; Al Kaabi AJ; Tariq S; Adeghate E; Goyal SN; Ojha S Free Radic Biol Med; 2021 May; 167():348-366. PubMed ID: 33588052 [TBL] [Abstract][Full Text] [Related]
16. β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats. Basha RH; Sankaranarayanan C Chem Biol Interact; 2016 Feb; 245():50-8. PubMed ID: 26748309 [TBL] [Abstract][Full Text] [Related]
17. Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice. Berger G; Arora N; Burkovskiy I; Xia Y; Chinnadurai A; Westhofen R; Hagn G; Cox A; Kelly M; Zhou J; Lehmann C Molecules; 2019 Nov; 24(23):. PubMed ID: 31766439 [TBL] [Abstract][Full Text] [Related]
18. Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction. Asth L; Cruz LC; Soyombo N; Rigo P; Moreira FA Curr Neuropharmacol; 2023; 21(2):213-218. PubMed ID: 36173065 [TBL] [Abstract][Full Text] [Related]
19. Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders. Ricardi C; Barachini S; Consoli G; Marazziti D; Polini B; Chiellini G Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542177 [TBL] [Abstract][Full Text] [Related]
20. The protective effects of β-caryophyllene on LPS-induced primary microglia M Askari VR; Shafiee-Nick R Life Sci; 2019 Feb; 219():40-73. PubMed ID: 30620895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]